Globus Medical, Inc. (GMED) Reports In-Line Q2 EPS; Cuts FY14 Revenue Outlook

Globus Medical, Inc. (NYSE: GMED) reported Q2 EPS of $0.23, in-line with the analyst estimate of $0.23. Revenue for the quarter came in at $113.6 million versus the consensus estimate of $119.83 million.

The company today revised its 2014 revenue guidance and now expects full year net sales to be in the range of $460 to $465 million. Full year Non-GAAP diluted earnings per share guidance remained unchanged, and is expected to be in the range of $0.90 to $0.92 per share of common stock.

*** The Street sees FY14 revs of $483.5 million and EPS of $0.94.

For earnings history and earnings-related data on Globus Medical, Inc. (GMED) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• Morgan Stanley Resumes Global Payments (GPN) at Equalweight
• Ennis (EBF) Reports In-Line Q1 EPS